Purchases and Sales Made in Q3 2024 in Puma Biotechnology, Inc. (PBYI)
This table provides information about the institutional ownership of Puma Biotechnology, Inc. (PBYI) during Q3 2024. The information is specifically focused on institutions that hold shares of PUMA BIOTECHNOLOGY, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 13, 2024
Q3 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-55- 0.03% |
$124 - $222
|
160K
$452K
|
|
|
Oct 08, 2024
Q3 2024
|
Cwm, LLC
|
SELL
|
- |
-254- 50.8% |
$572 - $1.02K
|
246
$694
|
|
|
Nov 13, 2024
Q3 2024
|
Panagora Asset Management Inc
Boston, MA |
SELL
|
- |
-791- 0.77% |
$1.78K - $3.19K
|
102K
$288K
|
|
|
Nov 12, 2024
Q3 2024
|
Sei Investments CO
Oaks, PA |
SELL
|
- |
-1.06K- 0.36% |
$2.37K - $4.25K
|
288K
$814K
|
|
|
Nov 12, 2024
Q3 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-3.64K- 7.24% |
$8.19K - $14.7K
|
46.6K
$131K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-4.74K- 40.77% |
$10.7K - $19.1K
|
6.89K
$19.4K
|
|
|
Nov 12, 2024
Q3 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-8.57K- 6.79% |
$19.3K - $34.6K
|
118K
$332K
|
|
|
Oct 10, 2024
Q3 2024
|
Ritholtz Wealth Management
|
SELL
|
- |
-12.2K- 36.02% |
$27.4K - $49K
|
21.6K
$60.9K
|
|
|
Nov 14, 2024
Q3 2024
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-22.2K- 45.72% |
$50K - $89.6K
|
26.4K
$74.4K
|
|
|
Oct 28, 2024
Q3 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-27.4K- 88.39% |
$61.7K - $110K
|
3.6K
$10.2K
|
|
|
Nov 12, 2024
Q3 2024
|
O'Shaughnessy Asset Management, LLC
Stamford, CT |
SELL
|
- |
-27.8K- 33.06% |
$62.6K - $112K
|
56.4K
$159K
|
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-32.8K- 3.45% |
$73.8K - $132K
|
917K
$2.59M
|
|
|
Nov 14, 2024
Q3 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-35K- 25.11% |
$78.8K - $141K
|
104K
$294K
|
|
|
Nov 14, 2024
Q3 2024
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-35.2K- 2.65% |
$79.2K - $142K
|
1.29M
$3.65M
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-42.3K- 13.06% |
$95.1K - $170K
|
281K
$794K
|
|
|
Nov 14, 2024
Q3 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-68.9K- 25.24% |
$155K - $278K
|
204K
$576K
|
|
|
Nov 12, 2024
Q3 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-100K- 84.23% |
$225K - $403K
|
18.7K
$52.9K
|
|
|
Nov 14, 2024
Q3 2024
|
Lazard Asset Management LLC
New York, NY |
SELL
|
- |
-107K- 99.55% |
$242K - $433K
|
490
$1.38K
|
|
|
Nov 05, 2024
Q3 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-140K- 73.92% |
$316K - $565K
|
49.5K
$140K
|
|
|
Nov 14, 2024
Q3 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-216K- 64.71% |
$486K - $871K
|
118K
$332K
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-282K- 8.91% |
$634K - $1.14M
|
2.88M
$8.12M
|